CIK: 1750050 - Address: C/O Roivant Sciences Ltd., 7Th Floor, 50 Broadway, London, X0 SW1H 0DB
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

12/26/24 21:00
12/23/24
ROIVRoivant Sciences Ltd.D0HealthDrugPharmaceutical PreparationsSukhatme MayukhX0DOP,Chief M.dm3,4123.850886518,837D
12/26/24 21:00
12/23/24
ROIVRoivant Sciences Ltd.D0HealthDrugPharmaceutical PreparationsSukhatme MayukhX0DOP,Chief S.dm-10,64212.010-886-418,837D
12/20/24 21:00
12/18/24
ROIVRoivant Sciences Ltd.D0HealthDrugPharmaceutical PreparationsSukhatme MayukhX0DOP,Chief M.d1,5883.850413218,837D
12/20/24 21:00
12/18/24
ROIVRoivant Sciences Ltd.D0HealthDrugPharmaceutical PreparationsSukhatme MayukhX0DOP,Chief S.d-4,97212.050-413-218,837D
4/2/24 21:00
3/30/24
ROIVRoivant Sciences Ltd.D0HealthDrugPharmaceutical PreparationsSukhatme MayukhX0DOP,Chief M.d00.000729165,310D
12/29/23 21:00
12/27/23
ROIVRoivant Sciences Ltd.D0HealthDrugPharmaceutical PreparationsSukhatme MayukhX0OP,Chief M.d00.0007114,947D
9/29/23 21:30
9/27/23
ROIVRoivant Sciences Ltd.D0HealthDrugPharmaceutical PreparationsSukhatme MayukhX0OP,Chief M.d00.0002814,875D
8/29/23 21:31
8/27/23
ROIVRoivant Sciences Ltd.D0HealthDrugPharmaceutical PreparationsSukhatme MayukhX0OP,Chief M.d00.0002304,848D
7/31/23 21:35
7/27/23
ROIVRoivant Sciences Ltd.D0HealthDrugPharmaceutical PreparationsSukhatme MayukhX0OP,Chief M.d00.0004314,825D
5/31/23 21:30
5/27/23
ROIVRoivant Sciences Ltd.D0HealthDrugPharmaceutical PreparationsSukhatme MayukhX0OSee RemaM.d00.0009924,782D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact